Skip to content

Johnson & Johnson CDR Price, Chart & Factor Exposure

Free Data & Analytics Access
Johnson & Johnson CDR · E.JNJ.NEO · Canada
Use symbol E.JNJ.NEO in our API & Excel add-in to retrieve this data ↓
—
(—)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum —
Trend —
Bubble Risk LOW
Realised Volatility (20D) —

Johnson & Johnson CDR Price Chart

MacroFinance.ai

Johnson & Johnson CDR Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Johnson & Johnson CDR
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Johnson & Johnson CDR
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Johnson & Johnson CDR
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for Johnson & Johnson CDR, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on Johnson & Johnson CDR

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

About Johnson & Johnson CDR (Canada)

Johnson & Johnson CDR is a listed security in Canada. This page shows the latest price and daily change, a price chart, its factor exposures and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Johnson & Johnson

Frequently asked questions

What is Johnson & Johnson CDR?
Johnson & Johnson CDR is a listed security in Canada. On MacroFinance its page shows the latest price and daily change, a price chart, its factor exposures and free historical data.
What factors affect Johnson & Johnson CDR?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Johnson & Johnson CDR, grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Where can I download free Johnson & Johnson CDR historical data?
In the Free historical data section of this page: the last 10 years of Johnson & Johnson CDR daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Johnson & Johnson CDR historical data (last 10 years)

Browse or instantly download the last 10 years of Johnson & Johnson CDR daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.JNJ.NEO&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-05-2928.95
2026-05-2829.78
2026-05-2729.75
2026-05-2629.61
2026-05-2529.9283
2026-05-2229.988
2026-05-2129.5803
2026-05-2029.3317
2026-05-1929.3914
2026-05-1529.0135
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.